Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical Study
RecruitingOBSERVATIONAL
Enrollment
75
Participants
Timeline
Start Date
August 25, 2020
Primary Completion Date
December 31, 2039
Study Completion Date
December 31, 2039
Conditions
Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product (PBCAR) in a Precision BioSciences, Inc., Clinical Study
Trial Locations (1)
90230
RECRUITING
Science 37, Inc., Culver City
All Listed Sponsors
lead
Imugene Limited
INDUSTRY
NCT05822427 - Long-term Follow-up of Study Participants Who Received an Allogeneic Chimeric Antigen Receptor T-Cell Product in an Imugene Ltd. Clinical Study | Biotech Hunter | Biotech Hunter